These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 711406)

  • 1. The development of a test system for inhibition of urinary oxalate lithiasis.
    O'Rear CE; Van't Riet B; Smith MJ
    Invest Urol; 1978 Sep; 16(2):163-5. PubMed ID: 711406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylene blue and other agents as inhibitors of calcium oxalithiasis in vivo.
    van't Riet B; O'Rear CE; Smith MJ
    Invest Urol; 1978 Nov; 16(3):201-3. PubMed ID: 101482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calcium oxalate urolithiasis in a rat model of lithogenesis using bisphosphonates.
    Gupta M; Tuncay OL; Valderrama E; Smith AD
    J Endourol; 1997 Feb; 11(1):1-4. PubMed ID: 9048290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
    Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental aspects of calcium oxalate tubular deposits and calculi induced in rat kidneys.
    Rushton HG; Spector M; Rodgers AL; Hughson M; Magura CE
    Invest Urol; 1981 Jul; 19(1):52-7. PubMed ID: 7251328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of magnesium salts on the course of experimental calcium-oxalate urolithiasis].
    Spasov AA; Iezhitsa IN; Kharitonova MV; Kravchenko MS
    Urologiia; 2011; (2):23-9. PubMed ID: 21815454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary calcium and magnesium on experimental renal tubular deposition of calcium oxalate crystal induced by ethylene glycol administration and its prevention with phytin and citrate.
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Ohkawa T
    Urol Int; 1987; 42(5):330-7. PubMed ID: 3433579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
    Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis.
    Yagisawa T; Ito F; Osaka Y; Amano H; Kobayashi C; Toma H
    J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urolithogenesis of mixed foreign body stones.
    Khan SR; Hackett RL
    J Urol; 1987 Nov; 138(5):1321-8. PubMed ID: 3312647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of experimental calcium oxalate monohydrate nephrolithiasis in rats.
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
    Scanning Microsc; 1994; 8(3):541-9; discussion 549-50. PubMed ID: 7747156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental morphology of calcium oxalate foreign body stones in rats.
    Khan SR; Hackett RL
    Calcif Tissue Int; 1985 Mar; 37(2):165-73. PubMed ID: 3924373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical studies on calcium urolithiasis: (I) Animal model for calcium oxalate urolithiasis using ethylene glycol and 1-alpha (OH) D3].
    Okada Y; Kawamura J; Nonomura M; Kuo YJ; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):565-77. PubMed ID: 4036734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature.
    Khan SR; Hackett RL
    Scan Electron Microsc; 1985; (Pt 2):759-74. PubMed ID: 3901237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are new-generation bisphosphonates effective for the inhibition of calcium oxalate stone formation in a rat model?
    Basok EK; Basaran A; Atsu N; Yildirim A; Tokuc R
    Urol Int; 2008; 81(3):325-9. PubMed ID: 18931552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation.
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; van 't Noordende JM; Schrder FH
    Scanning Microsc; 1995 Mar; 9(1):115-24; discussion 124-5. PubMed ID: 8553010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.